ST. LOUIS, Dec. 23 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company will hold an analyst conference call at 4:30 p.m. EST (3:30 p.m. CST) today to discuss the announcement of a voluntary suspension of shipments of approved tablet form drugs.
A live webcast of the conference call will be available to all investors at the KV Pharmaceutical Web site at http://www.kvpharmaceutical.com or at: http://w.on24.com/r.htm?e=130807&s=1&k=1085A5A957497D0BBDD698E02E17DCAF
For those who cannot listen to the live broadcast, an audio replay of the call will be available on these Web sites until March 25, 2009.
About KV Pharmaceutical Company
KV Pharmaceutical Company is a fully integrated specialty pharmaceutical company that develops, manufactures, markets, and acquires technology- distinguished branded and generic/non-branded prescription pharmaceutical products. The company markets its technology distinguished products through ETHEX Corporation, a national leader in pharmaceuticals that compete with branded products, and Ther-Rx Corporation, its branded drug subsidiary.
CONTACT: Catherine Biffignani, Vice President, Investor Relations of KV
Pharmaceutical Company, +1-314-645-6600, cbiffignani@kvpharmaceutical.com
Web site: http://www.kvpharmaceutical.com/
